We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China Revising GMPs for Sterile And Implantable Devices
China Revising GMPs for Sterile And Implantable Devices
The China Food and Drug Administration plans to revise its device good manufacturing practices to include specific GMPs for sterile and implantable devices. The revisions, outlined in a Feb. 9 draft guidance, aim to bring GMPs for these products up to par with international standards, Seth Goldenberg, director of global regulatory strategy at NAMSA, tells GMP.